ENLIVEX THERAPEUTICS LTD's ticker is ENLV and the CUSIP is M4130Y106. A total of 26 filers reported holding ENLIVEX THERAPEUTICS LTD in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $69 | +109.1% | 18,261 | +44.1% | 0.00% | – |
| Q2 2023 | $33 | -28.3% | 12,675 | -0.3% | 0.00% | – |
| Q1 2023 | $46 | +48.4% | 12,713 | +55.9% | 0.00% | – |
| Q4 2022 | $31 | -99.9% | 8,153 | +59.1% | 0.00% | – |
| Q3 2022 | $21,000 | +10.5% | 5,126 | +19.1% | 0.00% | – |
| Q2 2022 | $19,000 | -69.8% | 4,305 | -57.6% | 0.00% | – |
| Q4 2021 | $63,000 | -30.8% | 10,164 | +22.7% | 0.00% | – |
| Q1 2021 | $91,000 | +727.3% | 8,285 | +496.9% | 0.00% | – |
| Q4 2020 | $11,000 | – | 1,388 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 1,700,571 | $2,414,811 | 0.03% |
| XTX Topco Ltd | 24,820 | $35,244 | 0.00% |
| WELLS FARGO & COMPANY/MN | 9,184 | $13,041 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| UBS Group AG | 16 | $23 | 0.00% |
| OSAIC HOLDINGS, INC. | 400 | $568 | 0.00% |
| Global Retirement Partners, LLC | 11 | $16 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 10,420 | $14,796 | 0.00% |
| Activest Wealth Management | 1,000 | $1,420 | 0.00% |
| Citadel Advisors | 16,100 | $22,862 | 0.00% |